| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acceptable regret model in the end-of-life setting: Patients require high level of certainty before forgoing management recommendations
|
Tsalatsanis, Athanasios
|
|
2017
|
75 |
C |
p. 159-166
|
artikel
|
| 2 |
Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial
|
Chen, Lei
|
|
2017
|
75 |
C |
p. 150-158
|
artikel
|
| 3 |
Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy
|
Puliti, Donella
|
|
2017
|
75 |
C |
p. 109-116
|
artikel
|
| 4 |
Allergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy
|
Pradere, P.
|
|
2017
|
75 |
C |
p. 308-309
|
artikel
|
| 5 |
An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint®)
|
Makama, M.
|
|
2017
|
75 |
C |
p. 5-13
|
artikel
|
| 6 |
Anthropometrics at birth and risk of a primary central nervous system tumour: A systematic review and meta-analysis
|
Georgakis, Marios K.
|
|
2017
|
75 |
C |
p. 117-131
|
artikel
|
| 7 |
Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoids
|
Sullivan, Ivana
|
|
2017
|
75 |
C |
p. 259-267
|
artikel
|
| 8 |
A PET-based nomogram for oropharyngeal cancers
|
Castelli, J.
|
|
2017
|
75 |
C |
p. 222-230
|
artikel
|
| 9 |
Best available evidence related to clinical benefit of surgical resection in multimodality treatment of metastatic colorectal cancer indicates that a randomised controlled trial is warranted
|
Treasure, Tom
|
|
2017
|
75 |
C |
p. 310-312
|
artikel
|
| 10 |
Bladder cancer and smoking with special reference to education
|
Kawada, Tomoyuki
|
|
2017
|
75 |
C |
p. 1-2
|
artikel
|
| 11 |
Can chance cause cancer? A causal consideration
|
Stensrud, Mats Julius
|
|
2017
|
75 |
C |
p. 83-85
|
artikel
|
| 12 |
Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit
|
Papadatos-Pastos, Dionysis
|
|
2017
|
75 |
C |
p. 56-62
|
artikel
|
| 13 |
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
|
Duffy, M.J.
|
|
2017
|
75 |
C |
p. 284-298
|
artikel
|
| 14 |
Comparative analysis of PD-L1 expression between primary and metastatic pulmonary adenocarcinomas
|
Kim, Sehui
|
|
2017
|
75 |
C |
p. 141-149
|
artikel
|
| 15 |
Corrigendum to “Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours” [Eur J Cancer 69 (2016) 151–157]
|
Gizzi, Marco
|
|
2017
|
75 |
C |
p. 333
|
artikel
|
| 16 |
Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer
|
Franken, M.D.
|
|
2017
|
75 |
C |
p. 204-212
|
artikel
|
| 17 |
Distinct metastatic patterns in colorectal cancer patients based on primary tumour location
|
Hugen, Niek
|
|
2017
|
75 |
C |
p. 3-4
|
artikel
|
| 18 |
DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility
|
Ambatipudi, Srikant
|
|
2017
|
75 |
C |
p. 299-307
|
artikel
|
| 19 |
Does axillary lymph node dissection impact survival in patients with breast cancer and isolated tumour cells or micrometastasis in sentinel node?
|
Youssef, Mina M.G.
|
|
2017
|
75 |
C |
p. 167-168
|
artikel
|
| 20 |
Efficacy of the combination of ipilimumab and nivolumab following progression on pembrolizumab in advanced melanoma with poor risk features
|
Spain, Lavinia
|
|
2017
|
75 |
C |
p. 243-244
|
artikel
|
| 21 |
Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity
|
Bate-Eya, Laurel T.
|
|
2017
|
75 |
C |
p. 63-72
|
artikel
|
| 22 |
Exploratory analysis of biomarkers associated with clinical outcomes from the study of lenvatinib in differentiated cancer of the thyroid
|
Tahara, Makoto
|
|
2017
|
75 |
C |
p. 213-221
|
artikel
|
| 23 |
Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group
|
Irigoyen, Antonio
|
|
2017
|
75 |
C |
p. 73-82
|
artikel
|
| 24 |
Identification of microRNA biomarkers for response of advanced soft tissue sarcomas to eribulin: Translational results of the EORTC 62052 trial
|
Wiemer, Erik A.C.
|
|
2017
|
75 |
C |
p. 33-40
|
artikel
|
| 25 |
Impact of lymphopenia on prognosis of patients with primary central nervous system lymphoma
|
Schalk, Enrico
|
|
2017
|
75 |
C |
p. 280-283
|
artikel
|
| 26 |
Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma
|
Zimmer, Lisa
|
|
2017
|
75 |
C |
p. 47-55
|
artikel
|
| 27 |
Letter to the Editor regarding the paper by Park et al., Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)
|
Ieni, A.
|
|
2017
|
75 |
C |
p. 190-191
|
artikel
|
| 28 |
Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status
|
Giacchetti, Sylvie
|
|
2017
|
75 |
C |
p. 323-332
|
artikel
|
| 29 |
Looking back and to the future: Are we improving ‘cure’ in non-small cell lung cancer?
|
Walder, David
|
|
2017
|
75 |
C |
p. 192-194
|
artikel
|
| 30 |
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments
|
Kandolf Sekulovic, L.
|
|
2017
|
75 |
C |
p. 313-322
|
artikel
|
| 31 |
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
|
Cao, Su-Mei
|
|
2017
|
75 |
C |
p. 14-23
|
artikel
|
| 32 |
Phase-II trials in osteosarcoma recurrences: A systematic review of past experience
|
Omer, Natacha
|
|
2017
|
75 |
C |
p. 98-108
|
artikel
|
| 33 |
Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity
|
Gutzmer, Ralf
|
|
2017
|
75 |
C |
p. 24-32
|
artikel
|
| 34 |
Rationale for stimulator of interferon genes–targeted cancer immunotherapy
|
Rivera Vargas, Thaiz
|
|
2017
|
75 |
C |
p. 86-97
|
artikel
|
| 35 |
Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus
|
Holmberg, Dag
|
|
2017
|
75 |
C |
p. 41-46
|
artikel
|
| 36 |
Surgically treated oesophageal cancer developed in a radiated field: Impact on peri-operative and long-term outcomes
|
Markar, Sheraz R.
|
|
2017
|
75 |
C |
p. 179-189
|
artikel
|
| 37 |
Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based study
|
Rovers, Koen P.
|
|
2017
|
75 |
C |
p. 132-140
|
artikel
|
| 38 |
Survival of patients with melanoma brain metastasis treated with stereotactic radiosurgery and active systemic drug therapies
|
Choong, Ee Siang
|
|
2017
|
75 |
C |
p. 169-178
|
artikel
|
| 39 |
The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy
|
El-Galaly, Tarec Christoffer
|
|
2017
|
75 |
C |
p. 195-203
|
artikel
|
| 40 |
The proportion of circulating CD45RO+CD8+ memory T cells is correlated with clinical response in melanoma patients treated with ipilimumab
|
Tietze, Julia K.
|
|
2017
|
75 |
C |
p. 268-279
|
artikel
|
| 41 |
The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials
|
Roviello, Giandomenico
|
|
2017
|
75 |
C |
p. 245-258
|
artikel
|
| 42 |
The role of image-guided therapy in the management of colorectal cancer metastatic disease
|
de Baere, Thierry
|
|
2017
|
75 |
C |
p. 231-242
|
artikel
|
Tijdschrift beschrijving